Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults.

Wilens TE, Spencer TJ, Biederman J, Girard K, Doyle R, Prince J, Polisner D, Solhkhah R, Comeau S, Monuteaux MC, Parekh A.

Am J Psychiatry. 2001 Feb;158(2):282-8.

PMID:
11156812
2.

An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder.

Wilens TE, Prince JB, Spencer T, Van Patten SL, Doyle R, Girard K, Hammerness P, Goldman S, Brown S, Biederman J.

Biol Psychiatry. 2003 Jul 1;54(1):9-16.

PMID:
12842303
3.

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.

Levin FR, Evans SM, Brooks DJ, Kalbag AS, Garawi F, Nunes EV.

Drug Alcohol Depend. 2006 Feb 1;81(2):137-48. Epub 2005 Aug 15.

PMID:
16102908
4.

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.

Wilens TE, Biederman J, Prince J, Spencer TJ, Faraone SV, Warburton R, Schleifer D, Harding M, Linehan C, Geller D.

Am J Psychiatry. 1996 Sep;153(9):1147-53.

PMID:
8780417
5.

Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.

Kuperman S, Perry PJ, Gaffney GR, Lund BC, Bever-Stille KA, Arndt S, Holman TL, Moser DJ, Paulsen JS.

Ann Clin Psychiatry. 2001 Sep;13(3):129-34.

PMID:
11791949
6.

Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study.

Wilens TE, Haight BR, Horrigan JP, Hudziak JJ, Rosenthal NE, Connor DF, Hampton KD, Richard NE, Modell JG.

Biol Psychiatry. 2005 Apr 1;57(7):793-801.

PMID:
15820237
7.

Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression.

Daviss WB, Bentivoglio P, Racusin R, Brown KM, Bostic JQ, Wiley L.

J Am Acad Child Adolesc Psychiatry. 2001 Mar;40(3):307-14.

PMID:
11288772
9.
10.

Bupropion in adults with Attention-Deficit/Hyperactivity Disorder: a randomized, double-blind study.

Hamedi M, Mohammdi M, Ghaleiha A, Keshavarzi Z, Jafarnia M, Keramatfar R, Alikhani R, Ehyaii A, Akhondzadeh S.

Acta Med Iran. 2014;52(9):675-80.

11.

A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder.

Wilens TE, Biederman J, Spencer TJ, Bostic J, Prince J, Monuteaux MC, Soriano J, Fine C, Abrams A, Rater M, Polisner D.

Am J Psychiatry. 1999 Dec;156(12):1931-7.

PMID:
10588407
12.
13.

A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorder.

Manor I, Ben-Hayun R, Aharon-Peretz J, Salomy D, Weizman A, Daniely Y, Megiddo D, Newcorn JH, Biederman J, Adler LA.

J Clin Psychiatry. 2012 Dec;73(12):1517-23. doi: 10.4088/JCP.12m07767.

14.

Is response to OROS-methylphenidate treatment moderated by treatment with antidepressants or psychiatric comorbidity? A secondary analysis from a large randomized double blind study of adults with ADHD.

Biederman J, Mick E, Spencer T, Surman C, Faraone SV.

CNS Neurosci Ther. 2012 Feb;18(2):126-32. doi: 10.1111/j.1755-5949.2010.00233.x. Epub 2011 Aug 5.

PMID:
22070421
15.

Bupropion hydrochloride in attention deficit disorder with hyperactivity.

Conners CK, Casat CD, Gualtieri CT, Weller E, Reader M, Reiss A, Weller RA, Khayrallah M, Ascher J.

J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1314-21.

PMID:
8885585
16.

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K.

Arch Gen Psychiatry. 1995 Jun;52(6):434-43.

PMID:
7771913
17.

Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.

Wilens TE, Hammerness PG, Biederman J, Kwon A, Spencer TJ, Clark S, Scott M, Podolski A, Ditterline JW, Morris MC, Moore H.

J Clin Psychiatry. 2005 Feb;66(2):253-9.

PMID:
15705013
18.

Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder.

Wilens TE, Biederman J, Spencer TJ, Frazier J, Prince J, Bostic J, Rater M, Soriano J, Hatch M, Sienna M, Millstein RB, Abrantes A.

J Clin Psychopharmacol. 1999 Jun;19(3):257-64.

PMID:
10350032
19.
20.

Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.

Jafarinia M, Mohammadi MR, Modabbernia A, Ashrafi M, Khajavi D, Tabrizi M, Yadegari N, Akhondzadeh S.

Hum Psychopharmacol. 2012 Jul;27(4):411-8. doi: 10.1002/hup.2242.

PMID:
22806822

Supplemental Content

Support Center